A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

An advisory panel of the U.S. Centers for Disease Control and Prevention on Thursday recommended the use of Merck's ...

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...

A sign of the CDC is seen on a podium during the meeting of the members of the Advisory Committee on Immunization Practices, ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

The eight new ACIP members met for the first time on June 25 after Kennedy fired all 17 original members of the committee on June 9.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

Federal vaccine advisors on Thursday recommended Merck's new RSV antibody shot for infants younger than eight months old in ...

Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or ...

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

The newly formed Advisory Committee on Immunization Practices has voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug, clesrovimab, for infants younger than 8 months.